Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
A digital platform for personalized medicine for immuno-oncology and inflammatory dysfunctions
Innovative Solution
Blazar builds digital platforms for personalized medicine for immuno-oncology and inflammatory dysfunctions.
Investment Funding
Last Funding Stage
Pre-Seed
Last Funding Date
31-10-2019
Startup Stage
Seed
Lead Investors
Plug and Play, Entrepreneurs First
Revenue
Less than $1M
People
Founders
Dora Sabino
Renan Pereira
About
Blazar builds digital platforms for personalized medicine for immuno-oncology and inflammatory dysfunctions.
Something missing or incorrect on this page? Help us enrich this information
